Get started
Author

Víctor Sapena

Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regression
2021 · Lorenzo A. Orci, Marco Sanduzzi-Zamparelli, et al. · Clinical Gastroenterology and Hepatology · 227
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis
2021 · Victor Sapena, Marco Enea, et al. · Gut · 103
PDF
Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules
2019 · Zoe Mariño, Anna Darnell, et al. · Journal of Hepatology · 85
Assessing the impact of COVID-19 on liver cancer management (CERO-19)
2021 · Sergio Muñoz-Martínez, Victor Sapena, et al. · JHEP Reports · 64
Vitamin D Supplementation and Its Impact on Mortality and Cardiovascular Outcomes: Systematic Review and Meta-Analysis of 80 Randomized Clinical Trials
2023 · Antonio Ruiz-García, Vicente Pallarés-Carratalá, et al. · Nutrients · 59
PDF
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration
2023 · Álvaro Díaz-González, Manuel Hernández-Guerra, et al. · Hepatology · 57
PDF
Validation of the Simplified Magnetic Resonance Index of Activity [sMARIA] Without Gadolinium-enhanced Sequences for Crohn’s Disease
2020 · Nunzia Capozzi, Ingrid Ordás, et al. · Journal of Crohn s and Colitis · 46
Systematic review with meta‐analysis: the critical role of dermatological events in patients with hepatocellular carcinoma treated with sorafenib
2019 · Álvaro Díaz‐González, Marco Sanduzzi‐Zamparelli, et al. · Alimentary Pharmacology & Therapeutics · 44
PDF
Liver cancer risk after HCV cure in patients with advanced liver disease without non-characterized nodules
2021 · Marco Sanduzzi-Zamparelli, Zoe Mariño, et al. · Journal of Hepatology · 43
Outcome of patients with HCC and liver dysfunction under immunotherapy: a systematic review and meta-analysis
2023 · Ismael El Hajra, Marco Sanduzzi-Zamparelli, et al. · Hepatology · 37
PDF
Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma
2019 · Jordi Rimola, Alejandro Forner, et al. · European Radiology · 37
miR-200c-3p, miR-222-5p, and miR-512-3p Constitute a Biomarker Signature of Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma
2022 · Patricia de la Cruz-Ojeda, Tobias Schmid, et al. · Cells · 33
Radiological response to nivolumab in patients with hepatocellular carcinoma: A multicenter analysis of real-life practice
2020 · Jordi Rimola, Leonardo G. Da Fonseca, et al. · European Journal of Radiology · 28
PDF
Hepatic epithelioid hemangioendothelioma: An international multicenter study
2020 · Marco Sanduzzi-Zamparelli, Jordi Rimola, et al. · Digestive and Liver Disease · 28
Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity
2021 · Pablo Fernández-Tussy, Rubén Rodríguez-Agudo, et al. · Cell Death and Disease · 27
PDF
Improving primary prophylaxis of variceal bleeding by adapting therapy to the clinical stage of cirrhosis. A competing‐risk meta‐analysis of individual participant data
2023 · Càndid Villanueva, Victor Sapena, et al. · Alimentary Pharmacology & Therapeutics · 22
Avoiding contrast-enhanced sequences does not compromise the precision of the simplified MaRIA for the assessment of non-penetrating Crohn’s disease activity
2022 · Agnès Fernàndez-Clotet, Víctor Sapena, et al. · European Radiology · 22
Reliability of extracellular contrast versus gadoxetic acid in assessing small liver lesions using liver imaging reporting and data system v.2018 and European association for the study of the liver criteria
2022 · Jordi Rimola, Víctor Sapena, et al. · Hepatology · 21
Outcome of liver cancer patients with SARS‐CoV‐2 infection: An International, Multicentre, Cohort Study
2022 · Sergio Muñoz‐Martínez, Victor Sapena, et al. · Liver International · 19
PDF
Limited tumour progression beyond Milan criteria while on the waiting list does not result in unacceptable impairment of survival
2021 · Joana Ferrer-Fàbrega, Jaime Sampson-Dávila, et al. · Journal of Hepatology · 16
Does transient arterial-phase respiratory-motion-related artifact impact on diagnostic performance? An intra-patient comparison of extracellular gadolinium versus gadoxetic acid
2020 · Jordi Rimola, Anna Darnell, et al. · European Radiology · 15
Pharmacokinetics and pharmacogenetics of sorafenib in patients with hepatocellular carcinoma: Implications for combination trials
2020 · Álvaro Díaz‐González, Víctor Sapena, et al. · Liver International · 14
Influence of further decompensation on survival across clinical stages of decompensated cirrhosis: The role of portal hypertension and HVPG changes
2024 · Marta Garcia‐Guix, Alba Ardevol, et al. · Liver International · 13
PDF
Activated Lymphocytes and Increased Risk of Dermatologic Adverse Events during Sorafenib Therapy for Hepatocellular Carcinoma
2021 · Josep Corominas, Victor Sapena, et al. · Cancers · 9
PDF
Pancreatic Insufficiency in Patients Under Sorafenib Treatment for Hepatocellular Carcinoma
2020 · Álvaro Díaz-González, Ernest Belmonte, et al. · Journal of Clinical Gastroenterology · 7
Works count: 82
Citation count: 1,147
H-index: 19
I10-index: 23
Year
Topic
Type